反应详情

Using 4-[1-(1,1-dioxo-1λ6-isothiazolidin-2-yl)cyclopropyl]benzoic acid (141 mg) described in Preparation Example 31 and 1-(5-cyclopropyl-3-methylpyridin-2-yl)piperazine (114 mg) described in Preparation Example 83 and by the reaction and treatment in the same manner as in Example 87, the title compound (79 mg) was obtained.

1. customdescribed in Preparation Example 83 and by the reaction and treatment in the same manner as in Example 87